TY - JOUR
T1 - Acetylation and nuclear receptor action
AU - Wang, Chenguang
AU - Tian, Lifeng
AU - Popov, Vladimir M.
AU - Pestell, Richard G.
N1 - Funding Information:
This work was supported by grants from National Institute of Health [ R01CA70896 , R01CA75503 , and R01CA86072 to R.G.P.]. Work conducted at the Kimmel Cancer Center was supported by the NIH Cancer Center Core grant [ P30CA56036 to R.G.P.]. This project is funded in part by the Dr. Ralph and Marian C. Falk Medical Research Trust and a grant from Pennsylvania Department of Health (to R.G.P. and C.W.). The Department specifically disclaims responsibility for any analyses, interpretations or conclusions.
PY - 2011/2
Y1 - 2011/2
N2 - Acetylation is an essential post-translational modification featuring an acetyl group that is covalently conjugated to a protein substrate. Histone acetylation was first proposed nearly half a century ago by Dr. Vincent Allfrey. Subsequent studies have shown that the acetylated core histones are often associated with transcriptionally active chromatin. Acetylation at lysine residues of histone tails neutralizes the positive charge, which decreases their binding ability to DNA and increases the accessibility of transcription factors and coactivators to the chromatin template. In addition to histones, a number of non-histone substrates are acetylated. Acetylation of non-histone proteins governs biological processes, such as cellular proliferation and survival, transcriptional activity, and intracellular trafficking. We demonstrated that acetylation of transcription factors can regulate cellular growth. Furthermore, we showed that nuclear receptors (NRs) are acetylated at a phylogenetically conserved motif. Since our initial observations with the estrogen and androgen receptors, more than a dozen NRs have been shown to function as substrates for acetyltransferases with diverse functional consequences. This review focuses on the acetylation of NRs and the effect of acetylation on NR function. We discuss the potential role of acetylation in disease initiation and progression with an emphasis on tumorigenesis.
AB - Acetylation is an essential post-translational modification featuring an acetyl group that is covalently conjugated to a protein substrate. Histone acetylation was first proposed nearly half a century ago by Dr. Vincent Allfrey. Subsequent studies have shown that the acetylated core histones are often associated with transcriptionally active chromatin. Acetylation at lysine residues of histone tails neutralizes the positive charge, which decreases their binding ability to DNA and increases the accessibility of transcription factors and coactivators to the chromatin template. In addition to histones, a number of non-histone substrates are acetylated. Acetylation of non-histone proteins governs biological processes, such as cellular proliferation and survival, transcriptional activity, and intracellular trafficking. We demonstrated that acetylation of transcription factors can regulate cellular growth. Furthermore, we showed that nuclear receptors (NRs) are acetylated at a phylogenetically conserved motif. Since our initial observations with the estrogen and androgen receptors, more than a dozen NRs have been shown to function as substrates for acetyltransferases with diverse functional consequences. This review focuses on the acetylation of NRs and the effect of acetylation on NR function. We discuss the potential role of acetylation in disease initiation and progression with an emphasis on tumorigenesis.
KW - Acetylation
KW - Nuclear receptor action
UR - http://www.scopus.com/inward/record.url?scp=79151474217&partnerID=8YFLogxK
U2 - 10.1016/j.jsbmb.2010.12.003
DO - 10.1016/j.jsbmb.2010.12.003
M3 - Review article
C2 - 21167281
AN - SCOPUS:79151474217
SN - 0960-0760
VL - 123
SP - 91
EP - 100
JO - Journal of Steroid Biochemistry and Molecular Biology
JF - Journal of Steroid Biochemistry and Molecular Biology
IS - 3-5
ER -